Ghassan K Abou-Alfa MD

PubMed

• ASO Visual Abstract: Outcomes of First-versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma.
  Naaz Nasar, Misha Armstrong, Joanne F Chou, Mithat Gonen, Kevin C Soares
  Annals of Surgical Oncology. 2025-11-17
• Outcomes of First Versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma.
  Naaz Nasar, Misha Armstrong, Joanne F Chou, Mithat Gonen, Kevin C Soares
  Annals of Surgical Oncology. 2025-10-19
• Safety of immunotherapy after liver transplantation-A multicenter study of a prospective standardized clinical practice protocol.
  Kymberly D Watt, Saurav Panda, Valeria Pierluissi, Rachel Abarca, Danielle Rusch
  Liver Transplantation. 2025-10-13

Journal Articles

• Trans-arterial embolization for hepatocellular carcinoma: doxorubicin is not necessary  
  Karen T. Brown, Richard Kinh Do, Mithat Gonen, Anne M. Covey, George I. Getrajdman, Constintinos T. Sofocleous, William R. Jarnagin, Michael I. D�Angelica, Peter J. Al..., Translational Cancer Research, 1/1/2016
• Making Sense of the Advances in the Treatment of Hepatocellular Carcinoma  
  El-Dika, I, Abou-Alfa, GK, Oncology & Hematology Review, 1/1/2015
• Doxorubicin and Sorafenib in the Treatment of Hepatocellular Cracinoma  
  Abou-Alfa, GK, Capanu M, Saltz, L. In response to Pazo Cid, RA et al, JAMA, 1/23/2011
• Phase II Randomized, Double-Blind Study of Doxorubicin plus Sorafenib and Doxorubicin plus Placebo in Patients with Advanced Hepatocellular Carcinoma  
  Abou-Alfa, GK; Johnson, P; Knox, JK; Capanu, M; Davidenko, I; Lacava, J; Leung, T; Gansukh, B; Saltz, LB, Journal of the American Medical Association, 1/17/2010
• Join now to see all

Books/Book Chapters

• 100 Questions and Answers About Gallbaldder and biliary cancers 
  Abou-Alfa, GK; O�Reilly, EMJones and Bartlett, Sudbury, MAEdition 2nd,2017
• Abeloff's Clinical Oncology 
  Chapter: Liver and Bile Duct Cancer. 
  Abou-Alfa, GK, William Jarnagin, Maeve Lowery, Michael D�Angelica, Karen Brown, Emmy Ludwig, Anne Covey, Nancy Kemeny, Karyn A. Goodman, Jinru Shia, and Eileen M. O�...Editors: Abeloff, et al.Churchill Livingstone ElsevierEdition 5th,2013
• 100 Questions and Answers About Gallbaldder and biliary cancers 
  Abou-Alfa, GK; O�Reilly, EMJones and Bartlett, Sudbury, MAEdition 1st,2013
• DX/RX Hepatocellular Carcinoma. 
  Abou-Alfa, GK, Ang, CJones and Bartlett, Sudbury, MA2012
• 100 Questions and Answers About Liver Cancer 
  Abou-Alfa, GK; Dematteo, RJones and Bartlett, Sudbury, MAEdition 3rd,2012
• Surgery of the Liver, Biliary Tract, and Pancreas 
  Chapter: Advances in systemic therapy for hepatocellular carcinoma. 
  Page 307 - 403Harding, JJ, Connell, LC, and Abou-Alfa, GKEditors: Blumgart, L.Saunders Elsevier, Philadelphia, PAEdition 5th,2012
• Surgery of the Liver, Biliary Tract, and Pancreas 
  Chapter: Advances in systemic therapy for hepatocellular carcinoma 
  Page 1444 - 1452Abou-Alfa, GK; Saltz, LBEditors: Blumgart, L.Saunders Elsevier, Philadelphia, PAEdition 5th,2012
• Hepatocellular Carcinoma, A Multi-Disciplinary Approach 
  Chapter: Targeted Therapies for Hepatocellular Carcinoma 
  Page 355 - 368Feilchenfeldt, JW; O�Reilly, EM; Albany, C; and Abou-Alfa, GKEditors: McMasters, KM and Vauthey, J-N.Springer, New York, NY2011
• 2010 American Society of Clinical Oncology Educational Book 
  Chapter: Developing Drugs in Special Populations: Organ Dysfunction Studies. 2010 June 4-8; Chicago, Illinois 
  Abou-Alfa, GK, Mulkerin, D; and Huang, S-MAlexandria, VA2010
• Malignant Liver Tumors, Current and Emerging Therapies. 
  Chapter: Novel therapies targeted at sinal transduction in liver tumors. 
  Page 382 - 392Huitzil-Melendez, DF; Abou-Alfa, GK; Morse, MAEditors: Clavien, P.Jones and Bartlett, Sudbury, MAEdition 3rd,2010
• 100 Questions and Answers About Liver Cancer 
  Abou-Alfa, GK; Dematteo, RJones and Bartlett, Sudbury, MAEdition 2nd,2009
• Atlas of Cancer: Upper and Lower GI Tract Cancers volume 
  Chapter: Hepatobiliary Cancers. 
  Page 221 - 227Abou-Alfa, GK; Saltz, LBEditors: Markman, M..Springer2008
• 6Abeloff's Clinical Oncology 
  Chapter: Liver and Bile Duct Cancer. 
  S. Weber, W. Jarnagin, E.M. O'Reilly, A. Duffy, G.K. Abou-Alfa, L.H. BlumgartEditors: Abeloff, et al.Churchill Livingstone ElsevierEdition 4th,2008
• Surgery of the Liver, Biliary Tract, and Pancreas 
  Chapter: Chemotherapy of liver tumors: Systemic Therapy for Metastatic Colorectal Cancer 
  Page 1307 - 1311Abou-Alfa, GK; Saltz, LBEditors: Blumgart, L.Saunders Elsevier, Philadelphia, PAEdition 4th,2006
• Surgery of the Liver, Biliary Tract, and Pancreas 
  Chapter: Chemotherapy of liver tumors: Systemic Therapy for Hepatocellular Carcinoma 
  Page 1298 - 1306Abou-Alfa, GK; Saltz, LBEditors: Blumgart, L.Saunders Elsevier, Philadelphia, PAEdition 4th,2006
• 100 Questions and Answers About Liver Cancer 
  Abou-Alfa GKJones and Bartlett, Sudbury, MAEdition 1st,2004
• Malignant Liver Tumors, Current and Emerging Therapies. 
  Chapter: New Small Molecules Therapy for Liver Tumors. 
  Page 307 - 314Abou-Alfa, GK; Morse, MAEditors: Clavien, P.Jones and Bartlett, Sudbury, MAEdition 2nd,2004
• Clinical Oncology 
  Chapter: Liver and Bile Duct Cancer. 
  Page 1981 - 2013Weber, S; O'Reilly, E M; Abou-Alfa, GK; Blumgart, LEditors: Abeloff, M; Armitage, J; Lichter, A; and Niederhuber, J.Churchill Livingstone, Philadelphia, PAEdition 3rd,2004
• 2004 American Society of Clinical Oncology Educational Book 
  Chapter: Current and Novel Therapeutics for Hepatocellular Carcinoma; 2004 June 4-9; New Orleans, Louisiana 
  Page 192 - 197Abou-Alfa GKAlexandria, VA2004
• Join now to see all

Lectures

• Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELEST... 
  2019 ASCO Annual Meeting - 6/1/2019
• HCC: Newer treatment options for Advanced Hepatocellular Carcinoma, and Chemotherapy-resistant gastrointestinal malignancies particularly Hepatobiliary and pancreatic ... 
  Chennai, India - 1/24/2019
• A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HI... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
• Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
• HCC: Medical Oncologist's Perspective 
  Multiple Locations, 2015, 2016, 2018 - 1/26/2018
• Hematology and Medical Oncology Board Review 
  Memorial Sloan-Kettering Cancer Center, 2013, 2014, 2015, 2016, 2017, 2018 - 1/1/2018
• Improving Access and Quality of Healthcare in the Region 
  Wharton Business School of the University of Pennsylvania, Philadelphia, PA - 1/31/2017
• HCC: Systemic Treatment: Molecular Targeted Agents or Immune Checkpoint Inhibitors 
  1/27/2017
• Building Capacity, One Physician at a Time 
  Doha, Qatar - 1/22/2016
• Towards Individualized Therapies for Hepatocellular Carcinoma 
  Beaujon Hospital, Paris, France - 1/15/2014
• Advances in systemic therapy for HCC 
  1/6/2014
• Hepatocellular carcinoma & biliary cancers 
  Multiple Locations, 2010, 2013, 2014 - 1/1/2014
• ILCA 2013 - International Liver Cancer Association Seventh Annual Conference 
  International Liver Cancer Association (ILCA), Washington, Dist Of Col - 9/13/2013
• Hepatocellular Cancer: Clinical Heterogeneity and Treatment 
  Dublin, Ireland - 1/18/2013
• An Update on Systemic Therapy for Hepatocellular Carcinoma 
  Cork, Ireland - 1/16/2013
• Hepatocellular Carcinoma: Enhancing clinical outcomes in HCC 
  Rio De Janeiro, Brazil - 1/3/2013
• The Ninth Annual Meeting of the International Society of Gastrointestinal Oncology 
  The Johns Hopkins University School of Medicine, Arlington, Virginia - 9/13/2012
• Hepatocellular carcinoma: strategies to integrate sorafenib and other novel therapeutics into locoregional treatment 
  The Royal Marsden Hospital, London, United Kingdom - 1/30/2011
• How to Present Scientific Work 
  1/20/2009
• Hepatocellular Carcinoma 
  Multiple Locations, 2007, 2008, 2009 - 1/18/2009
• Join now to see all

Other

• How a cancer Patient Gives Back to Her Docto, on collaborative research development efforts between Bita Javadizadeh and Ghassan Abou-Alfa. 
  Abou-Alfa GK, Wall Street Journal
  https://www.wsj.com/articles/how-a-cancer-patient-gives-back-to-her-doctor-1476715884
  1/17/2016
• MSKCC's Ghassan Abou-Alfa discusses liver cancer new treatment options. 
  Abou-Alfa GK, LBCI
  1/9/2014
• MSKCC's Ghassan Abou-Alfa discusses causes of liver cancer and new treatment options. 
  Abou-Alfa GK, WCBS TV - Ch 2
  1/8/2007
• Hepatocellular Carcinoma, Stories 
  Abou-Alfa GK, ASCO, CancerPorgress.Net
  http://www.cancerprogress.net/stories.html
• Join now to see all